Setareh shamsili

Company: Coretag

Job title: CEO

Seminars:

From Bench to Bedside: The Story of CoreTag’s Targeted Radiotherapy 1:30 pm

Exploring the discovery and development of CoreTags lead targeted radiopharmaceutical asset, and challenges in early development Addressing preclinical challenges and showcasing strategies to overcome translational bottlenecks Looking to the future: What is next for Core Tag?Read more

day: Conference Day 2

Securing Buy-In from Pharma Partnerships and Investors 2:30 pm

How can we effectively present proof of concept, pharmacokinetic (PK), and toxicity data to persuade conservative investors to fund next-generation conjugate projects in Europe? Which specific metrics and evidence, such as efficacy data, market potential, or comparative advantages over existing therapies, are most persuasive for investors when considering funding for next-generation conjugates? In what ways…Read more

day: Conference Day 2